Skip to main content

Heather Ann Van Mater

Associate Professor of Pediatrics
Pediatrics, Rheumatology
T0909 Childrens Hlth Ctr, Box 3212, Durham, NC 27710

Overview


CNS vasculitis
Autoimmune encephalitis
Juvenile arthritis
Systemic vasculitis

Current Duke Appointments & Affiliations


Associate Professor of Pediatrics · 2021 - Present Pediatrics, Rheumatology, Pediatrics
Chief, Division of Rheumatology · 2020 - Present Pediatrics, Rheumatology, Pediatrics

Recent News Items


Published June 21, 2016
When the Body Attacks the Mind

View All News Items

Recent Scholarly Works


Life-Threatening Bradycardia in Anti-NMDA-Receptor Encephalitis and a Novel Use for Permanent Pacing.

Journal article Ann Clin Transl Neurol · May 2026 BACKGROUND: Pediatric anti-NMDA receptor encephalitis (pNMDARE) is an autoantibody-mediated disorder that can cause severe autonomic dysfunction, including symptomatic bradycardia and asystole. Dysautonomia can last for years, making it very challenging to ... Full text Open Access Link to item Cite

Anti-MOG IgG in EAE models clinical aspects of pediatric MOGAD.

Journal article Front Immunol · 2026 INTRODUCTION: Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is a severe, autoantibody-mediated neuroinflammatory syndrome that disproportionately impacts children. Detection of conformation-specific anti-MOG IgG1 in the seru ... Full text Link to item Cite

Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.

Journal article Pediatr Rheumatol Online J · October 21, 2025 BACKGROUND: Systemic juvenile idiopathic arthritis (SJIA) is a severe form of juvenile idiopathic arthritis characterized by fever, rash, chronic arthritis, and systemic inflammation. The introduction of biologics has improved the treatment options for SJI ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Phase III EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB

Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2025 - 2027

Phase 2/3, Children and Adolescents With Aquaporin-4 antibody Positive (AQP4-Ab [+]) Neuromyelitis Optica Spectrum Disorder (NMOSD)

Clinical TrialPrincipal Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2024 - 2026

Arthritis Foundation Fellowship Training Grant 2019

FellowshipCo Investigator · Awarded by Arthritis Foundation · 2020 - 2024

View All Grants

Education


University of Rochester · 2001 M.D.